semaglutide benefits beyond weight loss shows CV loss, study finds | Raj Reddy posted on the topic Everyone is talking about what

Whos Using GLP-1s and Why According to the survey, 1 in 10 adults currently use a GLP-1 medication, and a further 42% say theyve seriously considered starting treatment

With increasing numbers of patients diagnosed with diabetes, demand for such multi-indication therapy increases, forcing uniform adoption in developing and mature economies as well

Percentage of people hitting weight loss goals: Semaglutide: 50% lose 15%+ of body weight Tirzepatide: 63% lose 20%+ of body weight More people achieve significant weight loss with tirzepatide

GLP-1 RAs also improve insulin sensitivity, reduce ectopic fat deposition, and modulate adipose tissue metabolism by stimulating lipolysis and inhibiting lipogenesis [12, 13]